Austria vs Czechia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Austria
0.0%
in 2025
Czechia
0.0%
in 2025
Austria rank
167th
Czechia rank
167th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Austria
- Czechia
How they compare
Austria currently reports 0.0% against 0.0% in Czechia, a difference of 0.0%.
Across all 18 years both countries report, Czechia has been ahead every year.
Austria ranks 167th and Czechia ranks 167th of 194 countries.
Head to head by decade
| Decade | Austria | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 0.0% | 0.0% | 0.0% | β |
| 2020s | 0.0% | 0.0% | 0.0% | β |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Austria or Czechia?
- Austria, at 0.0% against 0.0% in Czechia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Austria and Czechia?
- 0.0%, with Austria ahead.
- How many years of comparable data are there for Austria and Czechia?
- 18 years are reported by both, from 2008 to 2025.
- How do Austria and Czechia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Austria ranks 167th and Czechia ranks 167th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.